高龄患者经锁骨下静脉植入人工永久心脏起搏器的安全性研究  

The case-control study of octogenarian patients implanted the cardiac pacemaker by subclavian vein

作　　者：陈全福[1] 张敏州[1] 李凡[2] 曹爱琴[1] 

机构地区：[1]广东省中医院ICU,广东广州510020 [2]深圳市南山区人民医院

出　　处：《西部医学》2010年第1期48-49,共2页Medical Journal of West China

摘　　要：目的评价高龄患者应用经锁骨下静脉植入人工永久心脏起搏器的安全性及临床意义。方法分析85例患者,以51例高龄(≥75岁)患者为研究组,以同期的中青年(≤60岁)患者34例为对照组,比较两组之间的心律失常类型、起搏模式、起搏参数,手术成功率及并发症等。结果高龄组与中青年组之间在心律失常构成方面有差异,高龄组患者的病窦综合征及房室传到阻滞多于中青年组,高龄组植入双腔起搏器少于中青年组。植入时的参数及并发症无明显差异,但是高龄患者的手术时间相对较长。结论高龄老年患者经锁骨下静脉起搏治疗的风险没有明显增加。Objective To evaluate the clinical effect in elderly patients implanted the cardiac pacemaker by subclavian vein. Methods Pacemaker were implanted in 51 octogenarians （octogenarians group） by subclavian vein, which was compared with 34 patients younger than 60 years. The type of bradyarrhythmia, pacing mode,pacing parameters, successful rate of operation and operative complications were observed. Results The incidences of sick sinus syndrome （SSS） and atrioventricular block （AVB） of octogenarians group were higher than that of the young group. In octogenari- ans group,implantation of dual chamber pacemaker was significantly less than that of control group. The success rate of operation was 100 % in two groups, whereas the rate of first successful subclavian vein puncture in octogenarians group was lower than that of control group. There was no difference in operative complication in two groups. Conclusion The risk of implanting operation by subclavian vein doesn＇t increase in octogenarians.

关 键 词：心血管 心脏起搏器 高龄 

分 类 号：R541.7[医药卫生—心血管疾病]